MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Leading Ventures
Parents
*Angel Investors: California
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Children
Anozyme
Charles Gathers
Hank Loy, a business development executive who now manages both InflammaGen and AnoZyme as the CEO of Leading Ventures’ portfolio companies.
InflammaGen
John Macfie
John Rodenrys, a senior managing director at Leading Venture
Leading Ventures funded five other biomedical technologies out of UCSD that it will move toward the trials process
San Diego, California
Serve as an alternative funding resource for early startups with long-term potential.
Jumps
2022: UC San Diego receives $150 million pledge for stem cell research